Release Date: August 15, 115 Statement Date: August 14, 115 Statement Time: 7:00:03 Company Code: 6949 Company Name: Peier Biomedical - Innovation Subject: Announcement of change in par value of company shares from "NT$10" to "NT$0.5". Announcement Period: August 6, 115 to November 5, 115. Applicable Clause: Item 51 Factual Date: July 13, 115 Details: 1. Factual Date: July 13, 115 2. Company Name: Peier Biomedical Technology & Pharmaceutical Co., Ltd. 3. Relationship with Company (enter '本公司' or 'Subsidiary'):本公司 4. Cross-shareholding Ratio: Not applicable 5. Reason for Occurrence: (1) Approval Date / Factual Date of Par Value Change: July 13, 115 (2) Approval Document Number for Par Value Change: M.O.E.A. Commercial Division No. 11530095510 (3) Board Resolution Date Approving Share Exchange Plan: August 6, 115 (4) Par Value Before Change: NT$10.00 (5) Par Value After Change: NT$0.50 (6) Listing Date of New Shares and Delisting Date of Old Shares: September 7, 115 (7) Material Information Announcement Date for Reissuing Shares: Material Information Announcement on August 6, 115 6. Countermeasures: None. 7. Other Matters to be Disclosed: 1. The company has approved the change of stock par value from NT$10 to NT$0.5 by the Taiwan Stock Exchange. 2. In conjunction with the par value change, the reference price on the first trading day of the new shares (September 7, 115) will be proportionally adjusted to 1/20 of the closing price of the old shares on their last trading day (August 26, 115). Investors are advised to take note. 3. After the par value change, earnings per share, net asset value per share, and share price per share will change. Please pay attention when reviewing such information.

FACT BOX

  • Source: PR Times
  • Category: News